CN107822195A - Relieving asthma and tobacco tar and relieving asthma electronic cigarette - Google Patents
Relieving asthma and tobacco tar and relieving asthma electronic cigarette Download PDFInfo
- Publication number
- CN107822195A CN107822195A CN201711058797.0A CN201711058797A CN107822195A CN 107822195 A CN107822195 A CN 107822195A CN 201711058797 A CN201711058797 A CN 201711058797A CN 107822195 A CN107822195 A CN 107822195A
- Authority
- CN
- China
- Prior art keywords
- asthma
- parts
- tobacco tar
- liquid
- relieving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A24F47/008—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Abstract
Relieving asthma and tobacco tar and relieving asthma electronic cigarette the present invention relates to one kind.The tobacco tar of relievining asthma includes base oil 89%~95% and asthma relieving liquid 5%~11% by mass percentage；Wherein, the base oil includes glycerine and propane diols；The asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：0.5~1.5 part of 2.5~3.5 parts of Chinese ephedra, 1.5~2.5 parts of cassia twig, 1.5~2.5 parts of almond and radix glycyrrhizae.Above-mentioned tobacco tar and the electronic cigarette of relievining asthma of relievining asthma, by acting on lung after configuring asthma relieving liquid directly atomization, with the antiasthmatic effect settled at one go, and avoid and absorbed by internal visceras such as stomach and intestine kidneys, alleviate the toxic side effect for user's internal viscera, both the profit of Chinese medicine had been obtained, the disadvantage of Chinese medicine has been kept away again, is to make the best of both worlds.
Description
Technical field
The present invention relates to electronic cigarette, more particularly to tobacco tar and the electronic cigarette of relievining asthma of relievining asthma.
Background technology
With the development of science and technology, electronic cigarette has become a kind of product being widely known by the people.Electronic cigarette is a kind of imitation cigarette
Electronic product, have outward appearance, smog, taste and the sensation as cigarette.It is by means such as atomizations, by tobacco tar
After component becomes steam, a kind of product for allowing user to suck.
In general tobacco tar is mixed by nicotine, propane diols, glycerine and essence etc., and tobacco tar unlike cigarette
In be free of tar, the design of generation electronic cigarette is complete from external form
First generation electronic cigarette is the shape for imitating common real smoke, and cigarette bullet is yellow, and smoke is white.This generation electronic cigarette
It is popular several years, because its external form is similar to real smoke, sensuously just received first by customer.But as people are to
The use of generation electronic cigarette is more and more, especially foreign customers, slowly found that first generation electronics in use
Many shortcomings of cigarette, mainly show above atomizer.The atomizer of first generation electronic cigarette is easy to blow, and is changing in addition
When cigarette bullet, the tip position of atomizer is easily hurt.Accumulate over a long period to grind away completely, finally result in atomizer and do not go out
Cigarette.Two generation electronic cigarettes are slightly longer than generation electronic cigarette, and diameter is generally 9.25 millimeters, and most important feature is that atomizer have passed through
Improve, carry protective cover outside atomizer, cigarette bullet is inserted into atomizer the inside, and to be atomizer be inserted into cigarette to generation electronic cigarette
Inside bullet, two contrasts.Two generation electronic cigarettes outstanding feature the most is exactly that cigarette bullet is merged with atomizer.3rd
It is to use disposable atomizer cigarette bullet for electronic cigarette, equivalent to atomizer and disposably, before solving the problems, such as, quality
Have greatly improved, and outward appearance and raw material are changed.
China is the inventor of electronic cigarette and main grown place, and the electronic cigarette in the whole world more than 90% is from China Shenzhen etc.
Ground, still, how using electronic cigarette the protection to lung is realized, be still unsolved technical problem.
The content of the invention
Based on this, it is necessary to provide one kind and relieving asthma and tobacco tar and relieving asthma electronic cigarette.
One kind is relievingd asthma tobacco tar, by mass percentage including base oil 89%~95% and asthma relieving liquid 5%~11%；Wherein,
The base oil includes glycerine and propane diols；The asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：Fiber crops
0.5~1.5 part of yellow 2.5~3.5 parts, 1.5~2.5 parts of cassia twig, 1.5~2.5 parts of almond and radix glycyrrhizae.
In one of the embodiments, the mass ratio of glycerine and propane diols is (1.5~3.5):1.
In one of the embodiments, the mass ratio of glycerine and propane diols is 2:1.
In one of the embodiments, the asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：Fiber crops
0.8~1.2 part of yellow 2.8~3.2 parts, 1.8~2.2 parts of cassia twig, 1.8~2.2 parts of almond and radix glycyrrhizae.
In one of the embodiments, the asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：Fiber crops
1 part of yellow 3 parts, 2 parts of cassia twig, 2 parts of almond and radix glycyrrhizae.
In one of the embodiments, Chinese ephedra goes section to handle.
In one of the embodiments, cassia twig peeling is handled.
In one of the embodiments, almond peeling point processing.
In one of the embodiments, radix glycyrrhizae is to process radix glycyrrhizae processed.
One kind is relievingd asthma electronic cigarette, and it includes the main frame, atomizer and cigarette holder being linked in sequence, is provided with the atomizer
State tobacco tar of being relievingd asthma described in any one.
Above-mentioned relieving asthma tobacco tar and electronic cigarette of relievining asthma, by acting on lung after configuring asthma relieving liquid directly atomization, there is a step
Antiasthmatic effect in place, and avoid and absorbed by internal visceras such as stomach and intestine kidneys, alleviate the poison pair for user's internal viscera
Effect, the profit of Chinese medicine is both obtained, the disadvantage of Chinese medicine is kept away again, is to make the best of both worlds.
Brief description of the drawings
Fig. 1 is the schematic diagram of one embodiment of the invention.
Embodiment
In order to facilitate the understanding of the purposes, features and advantages of the present invention, below in conjunction with the accompanying drawings to the present invention
Embodiment be described in detail.Many details are elaborated in the following description in order to fully understand this hair
It is bright.But the invention can be embodied in many other ways as described herein, those skilled in the art can be not
Similar improvement is done in the case of running counter to intension of the present invention, therefore the present invention is not limited by following public specific embodiment.
It should be noted that when element is referred to as " being fixed on " or " being arranged at " another element, it can be directly another
On one element or there may also be element placed in the middle.When an element is considered as " connection " another element, it can be with
It is directly to another element or may be simultaneously present centering elements.Term as used herein " vertically ", " level
", "left", "right" and similar statement for illustrative purposes only, it is unique embodiment to be not offered as.
Unless otherwise defined, all of technologies and scientific terms used here by the article is with belonging to technical field of the invention
The implication that technical staff is generally understood that is identical.Used term is intended merely to describe specific reality in the description of the invention
Apply the purpose of mode, it is not intended that in the limitation present invention.Term as used herein " and/or " include one or more correlations
The arbitrary and all combination of Listed Items.
For example, as shown in figure 1, one embodiment of the invention is, one kind is relievingd asthma tobacco tar, by mass percentage including base oil
89%~95% and asthma relieving liquid 5%~11%；Wherein, the base oil includes glycerine and propane diols；The asthma relieving liquid uses
Each proportioning component decocting liquid of following mass fraction obtains：2.5~3.5 parts of Chinese ephedra, 1.5~2.5 parts of cassia twig, 1.5~2.5 parts of almond
And 0.5~1.5 part of radix glycyrrhizae.So, by acting on lung after configuring asthma relieving liquid directly atomization, have what is settled at one go to relieving asthma
Effect, and avoid and absorbed by internal visceras such as stomach and intestine kidneys, the toxic side effect for user's internal viscera is alleviated, in both obtaining
The profit of medicine, the disadvantage of Chinese medicine is kept away again, be to make the best of both worlds.
For example, the tobacco tar of relievining asthma includes base oil 89% and asthma relieving liquid 11% by mass percentage；And for example, it is described to relieving asthma
Tobacco tar includes base oil 92% and asthma relieving liquid 8% by mass percentage；And for example, the tobacco tar of relievining asthma includes base by mass percentage
Oil 95% and asthma relieving liquid 5%；By that analogy.It is understood that contain water in the asthma relieving liquid, i.e. the asthma relieving liquid is adopted
With each proportioning component of following mass fraction：2.5~3.5 parts of Chinese ephedra, 1.5~2.5 parts of cassia twig, 1.5~2.5 parts of almond and sweet
0.5~1.5 part of grass, is obtained plus certain decocting liquid；The method of the component and decocting liquid of specific water, is referred to or uses
Existing Chinese medicine is boiled medicine technology realization, and requirement of of the invention and its each embodiment to this is that tobacco tar of relievining asthma includes base by mass percentage
Oil 89%~95% and asthma relieving liquid 5%~11%；In this case, according to the concentration of each proportioning component, 100% relievings asthma
The content of water in liquid is about 85%~98%, i.e., the content of the water in every a asthma relieving liquid is about 0.85~0.98 part, or
Say, using the quality of asthma relieving liquid as 100%, the content of its reclaimed water is about 85%~98%, and remaining embodiment is by that analogy.It is based on
This, terminal applies product of the invention can be divided into 100% asthma relieving liquid reclaimed water content be 85% tobacco tar of relievining asthma extremely,
Relieving asthma tobacco tar, the content of 100% asthma relieving liquid reclaimed water of the ultrahigh concentration that the content of 100% asthma relieving liquid reclaimed water is 88% is 91%
The high concentration middle concentration that tobacco tar, the content of 100% asthma relieving liquid reclaimed water be 94% of relievining asthma relieving asthma tobacco tar and 100% asthma relieving liquid
Low concentration of the content of reclaimed water more than 97% is relievingd asthma tobacco tar, so as to be directed to different degrees of asthma (asthma) dyspneic disease
Shape provides appropriate product.
The realization principle of electronic cigarette includes ultrasonic atomizatio or high-temperature atomizing (typically smaller than 60 degrees Celsius) etc., by tobacco tar of relievining asthma
Atomization is directly sucked in lung；In one of the embodiments, the mass ratio of glycerine and propane diols is (1.5~3.5):1.
In one of embodiment, the mass ratio of glycerine and propane diols is 2:1.It is appreciated that glycerine (Glycerol) and third
Glycol (Propylene Glycol) is the conventional basic material of base oil, and the outward appearance of propane diols is in colourless moisture absorption thick liquid, several
Tasteless odorless, can produce a part hits larynx sense；Glycerine is also known as glycerine, can be used as food sweetening agent, and outward appearance is in nothing
Color thick liquid, smells insipidness, band a little sweet taste of smoking.The base oil of of the invention and its each embodiment does not add
Nicotine (nicotine), this is and the maximum difference of the existing tobacco tar of in the market part.
Further, the base oil also includes additive；For example, the additive includes sweetener, acid, wet one's whistle agent
And/or deionized water etc.；For example, the additive includes butyl valerate, laurate, acetyl group pyrazine, vanillic aldehyde, nutmeg
Acid, cinnamic acid and/or peppermint oil etc.；Further, the base oil also includes butyl valerate and laurate, for example, butyl valerate,
The mass ratio of laurate and propane diols is (0.025~0.04):(0.03~0.045):1.For example, butyl valerate, laurate
Mass ratio with propane diols is 0.03:0.035:1.And/or further, the base oil also includes acetyl group pyrazine and perfume
Lan Su, for example, the mass ratio of acetyl group pyrazine, vanillic aldehyde and propane diols is (0.03~0.05):(0.02~0.04):1.Example
Such as, the mass ratio of acetyl group pyrazine, vanillic aldehyde and propane diols is 0.04:0.03:1.Acetyl group pyrazine can increase fragrance, have
Nut fruits taste, tobacco tar mellow in taste can be made；Vanillic aldehyde (Vanillin), also known as vanillic aldehyde, by increasing capacitance it is possible to increase delicate fragrance atmosphere, keep away
Exempt to cross soapy feeling feel caused by propane diols.And/or further, the base oil also includes myristic acid and cinnamic acid, for example,
The mass ratio of myristic acid, cinnamic acid and propane diols is (0.01~0.02):(0.01~0.02):1.For example, myristic acid
Mass ratio with cinnamic acid is 1:(1~2), for example, the mass ratio of myristic acid and cinnamic acid is 1:1.5；For example, Pork and beans
The mass ratio of cool acid, cinnamic acid and propane diols is 0.01:0.015:1.Tobacco tar of relievining asthma equipped with myristic acid and cinnamic acid, energy
Giving off a strong fragrance is enough provided, acts on venturi, has mellow aromatic gas sense, coordinates the use of asthma relieving liquid, helps to provide and preferably relievings asthma
Effect.And/or further, the base oil also includes peppermint oil, the mass ratio of peppermint oil and propane diols for (0.01~
0.018):1；For example, the mass ratio of peppermint oil and propane diols is 0.016:1.
Further, the additive includes or also included grape wine；For example, grape wine can use commercial glucose wine；Example
Such as, the base oil also includes grape wine, and the mass ratio of grape wine and propane diols is (0.2~0.6):1；For example, grape wine with
The mass ratio of propane diols is 0.4:1.So, using it is described relieving asthma tobacco tar when, strong vinous flavor can be experienced, this
It is the experience of relievining asthma never occurred so that user has reached antiasthmatic effect in similar to the sensation for drinking pure wine.Further
Ground, the additive include or also included beef extract；For example, beef extract can use commercially available beef extract；For example, the base oil also wraps
Include beef extract, the mass ratio of beef extract and propane diols is (0.05~0.08):1；For example, the mass ratio of beef extract and propane diols
Example is 0.06:1.Beef extract (Beef Extract) is also known as beef extract, be using fresh beef through rejecting fat, digestion,
Filter, a kind of paste of brown color obtained from concentration to sepia.There is beef nature fragrance, soluble in water, the aqueous solution is in
It is faint yellow.So, using it is described relieving asthma tobacco tar when, can experience that strong beef is fragrant, this is relievining asthma of never occurring
Experience so that user has reached antiasthmatic effect in the sensation similar to utility beef.For example, the base oil also includes grape wine
With beef extract, the mass ratio of grape wine, beef extract and propane diols is (0.2~0.6):(0.05~0.08):1, for example, grape
The mass ratio of wine, beef extract and propane diols is 0.4:0.06:1.
In one of the embodiments, the asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：Fiber crops
0.8~1.2 part of yellow 2.8~3.2 parts, 1.8~2.2 parts of cassia twig, 1.8~2.2 parts of almond and radix glycyrrhizae.One embodiment wherein
In, the asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：3 parts of Chinese ephedra, 2 parts of cassia twig, 2 parts of almond and
1 part of radix glycyrrhizae.In one of the embodiments, Chinese ephedra goes section to handle.And/or in one of the embodiments, at cassia twig peeling
Reason.And/or in one of the embodiments, almond peeling point processing.And/or in one of the embodiments, radix glycyrrhizae is to process
Radix glycyrrhizae processed.In each embodiment, the dosage of specific decocting liquid and water, the setting of tobacco tar concentration is relievingd asthma i.e. according to target asthma relieving liquid or target
Can.
In one of the embodiments, the proportioning component of the asthma relieving liquid also includes：3.5~4.5 parts of the bighead atractylodes rhizome or coix seed；
That is, described asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, cassia twig 1.8~2.2
Part, 1.8~2.2 parts of almond, the bighead atractylodes rhizome or 0.8~1.2 part of 3.5~4.5 parts of coix seed and radix glycyrrhizae, remaining embodiment is with such
Push away.For example, the asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, cassia twig 1.8
0.8~1.2 part of~2.2 parts, 1.8~2.2 parts of almond, 3.5~4.5 parts of the bighead atractylodes rhizome and radix glycyrrhizae；And for example, the asthma relieving liquid use with
Each proportioning component decocting liquid of lower mass fraction obtains：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, 1.8~2.2 parts of almond,
0.8~1.2 part of 3.5~4.5 parts of coix seed and radix glycyrrhizae.
In one of the embodiments, the proportioning component of the asthma relieving liquid also includes：2.5~3.5 parts of ginger；That is, it is described
Asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, almond
0.8~1.2 part of 1.8~2.2 parts, 2.5~3.5 parts of ginger and radix glycyrrhizae, remaining embodiment is by that analogy.For example, described relieving asthma
Liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, almond 1.8
0.8~1.2 part of~2.2 parts, 3.5~4.5 parts of the bighead atractylodes rhizome, 2.5~3.5 parts of ginger and radix glycyrrhizae.And for example, the asthma relieving liquid use with
Each proportioning component decocting liquid of lower mass fraction obtains：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, 1.8~2.2 parts of almond,
0.8~1.2 part of 3.5~4.5 parts of coix seed, 2.5~3.5 parts of ginger and radix glycyrrhizae.
In one of the embodiments, the proportioning component of the asthma relieving liquid also includes：0.5~1.5 part of jujube；That is, it is described
Asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, almond
0.8~1.2 part of 1.8~2.2 parts, 0.5~1.5 part of jujube and radix glycyrrhizae, remaining embodiment is by that analogy.For example, described relieving asthma
Liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, almond 1.8
0.8~1.2 part of~2.2 parts, 3.5~4.5 parts of the bighead atractylodes rhizome, 2.5~3.5 parts of ginger, 0.5~1.5 part of jujube and radix glycyrrhizae.And for example,
The asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig,
1.8~2.2 parts of almond, 3.5~4.5 parts of coix seed, 2.5~3.5 parts of ginger, 0.5~1.5 part of jujube and radix glycyrrhizae 0.8~1.2
Part.
In one of the embodiments, the proportioning component of the asthma relieving liquid also includes：2.5~3.5 parts of perilla seed；That is, institute
Asthma relieving liquid is stated to obtain using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, apricot
0.8~1.2 part of 1.8~2.2 parts of benevolence, 2.5~3.5 parts of perilla seed and radix glycyrrhizae, remaining embodiment is by that analogy.It is for example, described
Asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, almond
1.8~2.2 parts, 3.5~4.5 parts of the bighead atractylodes rhizome, 2.5~3.5 parts of ginger, 0.5~1.5 part of jujube, 2.5~3.5 parts of perilla seed and
0.8~1.2 part of radix glycyrrhizae.And for example, the asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：Chinese ephedra 2.8~
3.2 parts, 1.8~2.2 parts of cassia twig, 1.8~2.2 parts of almond, 3.5~4.5 parts of coix seed, 2.5~3.5 parts of ginger, jujube 0.5~
0.8~1.2 part of 1.5 parts, 2.5~3.5 parts of perilla seed and radix glycyrrhizae.In each embodiment, perilla seed is frying perilla seed.
In one of the embodiments, the proportioning component of the asthma relieving liquid also includes：2.5~3.5 parts of the root bark of white mulberry；That is, institute
Asthma relieving liquid is stated to obtain using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, apricot
0.8~1.2 part of 1.8~2.2 parts of benevolence, 2.5~3.5 parts of the root bark of white mulberry and radix glycyrrhizae, remaining embodiment is by that analogy.It is for example, described
Asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, almond
1.8~2.2 parts, 3.5~4.5 parts of the bighead atractylodes rhizome, 2.5~3.5 parts of ginger, 0.5~1.5 part of jujube, 2.5~3.5 parts of perilla seed, Sang Bai
0.8~1.2 part of 2.5~3.5 parts of skin and radix glycyrrhizae.For example, the asthma relieving liquid is decocted using each proportioning component of following mass fraction
Liquid obtains：3 parts of Chinese ephedra, 2 parts of cassia twig, 2 parts of almond, 4 parts of the bighead atractylodes rhizome, 3 parts of ginger, 1 part of jujube, 3 parts of perilla seed, 3 parts of the root bark of white mulberry with
And 1 part of radix glycyrrhizae, remaining embodiment is by that analogy.And for example, the asthma relieving liquid uses each proportioning component decocting liquid of following mass fraction
Obtain：2.8 parts of Chinese ephedra, 2.2 parts of cassia twig, 2.2 parts of almond, 3.5 parts of coix seed, 2.5 parts of ginger, 0.5 part of jujube, perilla seed 3.5
1.2 parts of part, 2.5 parts of the root bark of white mulberry and radix glycyrrhizae, remaining embodiment is by that analogy.
Further, the asthma relieving liquid is obtained using each proportioning component decocting liquid of mass fraction described in the various embodiments described above：
By each proportioning component decocting liquid of respective quality number, decoction is obtained, then medical filtration mixes according to mass percent and base oil
It is even, for example, decoction 5%~11% and base oil 89%~95% are mixed by mass percentage.For example, the asthma relieving liquid use with
Each proportioning component decocting liquid of lower mass fraction obtains：Go section handle 2.5~3.5 parts of Chinese ephedra, peeling processing cassia twig 1.5~
2.5 parts, peeling point processing 1.5~2.5 parts of almond and process 0.5~1.5 part of radix glycyrrhizae processed, mud of pulverizing, then decocting liquid, is obtained
To liquid be decoction, i.e. decocting liquid obtains decoction, will after medical filtration by mass percentage with base oil mix.And for example, it is described
Asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.5~3.5 parts of Chinese ephedra, 1.5~2.5 parts of cassia twig, almond
1.5~2.5 parts, 3.5~4.5 parts of the bighead atractylodes rhizome, 2.5~3.5 parts of ginger, 0.5~1.5 part of jujube, 2.5~3.5 parts of perilla seed, Sang Bai
0.5~1.5 part of 2.5~3.5 parts of skin and radix glycyrrhizae, decocting liquid obtains decoction, will be mixed by mass percentage with base oil after medical filtration
It is even.In other each embodiments, when other proportioning components be present, same processing, repeat no more.Further, it is filtered
Afterwards, also carry out concentration, remove moisture content, volume is concentrated into as 20%~50% of volume after filtering, to be used as final medicine
Liquid, mixed according to mass percent and base oil.
In one of the embodiments, the proportioning component of the asthma relieving liquid also includes：3~5 parts of honey；That is, it is described to relieving asthma
Liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, almond 1.8
0.8~1.2 part of~2.2 parts, 3~5 parts of honey and radix glycyrrhizae, remaining embodiment is by that analogy.Honey has heat-clearing, bowl spares and profit
Dry analgesic and other effects.For example, in each embodiment, each proportioning component before the asthma relieving liquid decocting liquid also includes：3~5 parts of honey.
And for example, the asthma relieving liquid includes decoction and honey, and the decoction is each proportioning that the various embodiments described above use each mass fraction
The liquid that component decocting liquid obtains；For example, the mass ratio of the decoction and the honey is (2~4):1；For example, the decoction
Mass ratio with the honey is 2:1、2.5:1、3:1、3.5:1 or 4:1.So, decocting liquid processing is carried out without to honey, directly
Connect, especially mixing use mixed with decoction using honey.For example, by mass percentage by asthma relieving liquid 5%~11% with
Base oil 89%~95% mixes, and decoction in asthma relieving liquid and the mass ratio of honey are (2~4):1.
Further, in each embodiment, base oil mixes with asthma relieving liquid；For example, in sealing ring after base oil and asthma relieving liquid mixing
Placed 12~48 hours or more under border；And/or its base oil and asthma relieving liquid are mixed before tobacco tar is relievingd asthma in use.So, respectively
The tobacco tar of relievining asthma of embodiment has preferable homogeneity, is easy to follow-up atomization process.
The tobacco tar of relievining asthma of various embodiments of the present invention, using Mahuang Tang as the dialectical basis of Chinese medicine, with reference to base oil and atomizing type, energy
It is enough to realize that to respiratory tract medicine toxicity is low until lung's direct drug injection, absorbs without internal organs such as internal stomach and intestine, and can with
The less condition of dose is issued to preferably antiasthmatic effect.
One kind is relievingd asthma electronic cigarette, and it includes the main frame, atomizer and cigarette holder being linked in sequence, is provided with the atomizer
State tobacco tar of being relievingd asthma described in any embodiment.So, atomization, Ran Houtong are realized to the tobacco tar of relievining asthma by host computer control atomizer
Cross cigarette holder to be inhaled by the user, respiratory tract can be directly acted on until lung, without internal internal organs, reduces various Chinese medicines
Composition unverified toxic side effect that may be present to internal internal organs.
For example, the electronic cigarette of relievining asthma is additionally provided with the tobacco tar input unit being detachably connected with the atomizer；The cigarette
Oily input unit is used to deposit the tobacco tar of relievining asthma, and when being connected with the atomizer, controlled the described of input predetermined quantity is put down
Tobacco tar is breathed heavily into the atomizer, and tobacco tar of being relievingd asthma described in any of the above-described embodiment is provided with the atomizer to realize.For example,
The tobacco tar input unit is provided with input end, and the tobacco tar input unit is when controlled by the input end to the atomization
The tobacco tar of relievining asthma of device input predetermined quantity.For example, the input end is quantitative input end or constant volume input end；Example
Such as, the tobacco tar input unit is provided with quantitative input end, and the tobacco tar input unit passes through the quantitative input when controlled
Portion inputs tobacco tar of being relievingd asthma described in predetermined quality to the atomizer.And for example, the tobacco tar input unit is provided with constant volume input
Portion, the tobacco tar input unit pass through the constant volume input end when controlled and input the described flat of predetermined to the atomizer
Breathe heavily tobacco tar.
Further, the tobacco tar input unit be provided with storage area, the input end connected with the storage area and by
Laminated structure；The storage area is provided with inlet, and the storage area is used for by tobacco tar of being relievingd asthma described in inlet injection；Institute
State input end and be sequentially set with connection end, body and connecting portion, the connection end connects the storage area, the connecting portion with
The atomizer is detachably connected, i.e., described tobacco tar input unit is detachably connected by the connecting portion and the atomizer；Enter
One step, the connection end, the body are wholely set with the connecting portion, and the pressing structure abuts with the body, and
The body has flexible shell, and the flexible shell is used for the stress when the pressing structure is pressed and deformed upon, so as to
The tobacco tar of relievining asthma of the tubular body is expressed into the atomizer by the connecting portion.For example, in each embodiment, the company
Socket part has outer wall connection structure and inner tube, and the outer wall connection structure is detachably connected with the atomizer；For example, in described
In cylinder, cylindrical diameter is more than 0.8 millimeter and less than 1.2 millimeter pipe, with smooth and avoid taking between residual in passage
Obtain balance necessarily.Further, the pressing structure is slidably socketed outside the body, for when stress presses along institute
The bearing of trend for stating body slides, so as to which the tobacco tar of relievining asthma of the tubular body is expressed into the atomization by the connecting portion
Device.
And for example, the tobacco tar input unit is provided with storage area, the input end connected with the storage area and pressing knot
Structure；The storage area is provided with inlet, and the storage area is used for by tobacco tar of being relievingd asthma described in inlet injection；It is described defeated
Enter end and be sequentially set with connection end, body and connecting portion, the connection end connects the storage area, the connecting portion with it is described
Atomizer is detachably connected, i.e., described tobacco tar input unit is detachably connected by the connecting portion and the atomizer；The company
Socket part is provided with lower valve, and the pressing structure is connected with the lower valve of the connecting portion, for pressing time control in stress
The lower valve is made to open and restore when not stressing to control the lower valve to close, with realize the tobacco tar input unit by
Tobacco tar of being relievingd asthma described in predetermined quantity is inputted to the atomizer by the input end during control；Further, the connection
End is provided with valve, and the upper valve of the pressing structure also with the connection end is connected, for pressing time control in stress
Make the upper valve to close and restore to control valve opening on described when not stressing, to coordinate lower valve to realize linkage control
System, and then control the tobacco tar input unit to input the institute of predetermined quantity when controlled to the atomizer by the input end
State tobacco tar of relievining asthma；That is, when not pressing pressing structure, upper valve opening and lower valve is closed is flat in storage area
Breathe heavily tobacco tar to enter in the body of input end, when pressing pressing structure, upper valve is closed lower valve and opened, the pipe of input end
Tobacco tar of relievining asthma in body enters the atomizer by lower valve, every time only between the upper valve and lower valve in I/O portion
Volume tobacco tar of relievining asthma, so as to reach constant volume output effect.For example, the pressing structure is sequentially set with pedestal, spring
With pressure cap, the pressing structure is additionally provided with two connectors, a upper valve of connector connection, the connection of another connector
Lower valve.And for example, the tubular body also sets up slip push jack, and the slip push jack is connected with the pressing structure, for
When the pressing structure is pressed, the tobacco tar boosting of relievining asthma of the tubular body is sent at lower valve.And for example, the tobacco tar is defeated
Enter portion and its input end is removably attachable to the top of the atomizer, to pass through Action of Gravity Field, controlled input predetermined number
The described of amount relievings asthma tobacco tar into the atomizer.In other embodiments of the invention, it can also design and various determine quality or constant volume
The long-pending way of output, will not be repeated here.
Further, the tobacco tar input unit is additionally provided with air pump, and it is defeated that the air pump is removable installed in the tobacco tar
Enter for example described air pump in portion and be removable installed in the storage area, the output end of the air pump connects the inlet, described
Air pump is used to, by relievining asthma tobacco tar to after the storage area described in inlet injection, be pumped into gas to push the storage
The tobacco tar of relievining asthma in area and the input end enters the atomizer, so as to realize the tobacco tar input unit when controlled
Tobacco tar of being relievingd asthma described in predetermined quantity is inputted to the atomizer by the input end.For example, the air pump pass through it is removable
Unload rotating shaft axle and be connected to the tobacco tar input unit；For example, the cough-relieving electronic cigarette is provided with circular connector, the circular connector
It is socketed on the outside of the storage area, or, the circular connector is socketed on the outside of the tobacco tar input unit, and for example, the ring
Shape connector is socketed on the outside of the tobacco tar input unit and adjacent to the inlet of the storage area；Wherein, the annular
Connector has been provided projectingly convex portion, and the convex portion offers groove, and the air pump is connected to the tobacco tar by detachable rotating shaft axle
In the groove of input unit；And for example, the air pump is bolted in the tobacco tar input unit；It is appreciated that the gas in each embodiment
Pump or other structures can be provided with power connection end, relieving asthma tobacco tar to the atomization described in injection for accessing external power source to realize
Device, the air pump and/or other structures are removed when in use.And for example, the tobacco tar input unit is removed when in use,
While convenient input relievings asthma tobacco tar to the atomizer, the use for the electronic cigarette that do not influence also to relieving asthma, is to kill two birds with one stone.
For example, the storage area offers the first liquid storage area, the second liquid storage area and mixed zone；The inlet includes first
Branch and the second injection branch are injected, the first injection branch connects first liquid storage area, and first liquid storage area is used for
Accommodating base oil, the second injection branch connect second liquid storage area, and second liquid storage area is used to house asthma relieving liquid, described
Mixed zone be arranged at the lower section of first liquid storage area and second liquid storage area and be respectively communicated with first liquid storage area with
Second liquid storage area, the connection end are located at the lower section of the mixed zone and connect the mixed zone, and the mixed zone is used for
The base oil of first liquid storage area and the asthma relieving liquid of second liquid storage area are accepted, and is mixed, after asthma relieving liquid is mixed
Asthma relieving liquid is set to enter by the connection end of the input end in the body.For example, the mixed zone is provided with mixing
Cavity and its control valve, the mixing chamber are arranged at the lower section of first liquid storage area and second liquid storage area and difference
Connect first liquid storage area and second liquid storage area, the mixing chamber be used to accepting the base oil of first liquid storage area with
The asthma relieving liquid of second liquid storage area, the control valve is used to turning on or closing the mixing chamber, so that the mixing chamber
Relative to connection end conducting or closing, so, when control valve turns on the mixing chamber, the mixing chamber passes through institute
State control valve and connect the connection end, when controlling mixing chamber described in valve closure, the mixing chamber does not connect the connection
End；Also, the mixed zone is provided with mixing structure in the mixing chamber, for example, the mixing structure is agitator；Enter
One step, the mixing structure is magnetic stirring apparatus, and the magnetic stirring apparatus is used to mix the mixing chamber during controlled rotation
In base oil and asthma relieving liquid.Further, the tobacco tar input unit is additionally provided with air pump, and the air pump is removable installed in institute
Storage area is stated, and the output end of the air pump connects with the described first injection branch and the second injection branch respectively, uses
Gas is pumped into injecting branch by the described first injection branch and described second respectively after the mixed zone mixing asthma relieving liquid
The atomizer is entered with tobacco tar of relievining asthma described in pushing in the storage area and the input end, so as to realize the tobacco tar
Input unit passes through the input end when controlled and inputs tobacco tar of being relievingd asthma described in predetermined quantity to the atomizer.
Further, the storage area is further opened with the 3rd liquid storage area, for example, the storage area offers the first liquid storage
Area, the second liquid storage area, the 3rd liquid storage area and mixed zone；The inlet includes the first injection branch second and injects branch and the 3rd
Inject branch, the first injection branch connects first liquid storage area, and first liquid storage area is used to housing base oil, and described the
Two injection branches connect second liquid storage area, and second liquid storage area is used for the decoction for housing asthma relieving liquid, the 3rd injection
Branch connects the 3rd liquid storage area, and the 3rd liquid storage area is used for the honey for housing asthma relieving liquid, and the mixed zone is arranged at institute
State the first liquid storage area, second liquid storage area and the 3rd liquid storage area lower section and be respectively communicated with first liquid storage area,
Second liquid storage area and the 3rd liquid storage area, the connection end are located at the lower section of the mixed zone and connect the mixing
Area, the mixed zone be used to accepting the base oil of first liquid storage area, second liquid storage area asthma relieving liquid decoction with it is described
The honey of the asthma relieving liquid of 3rd liquid storage area, and mixed, pass through the connection of the input end after mixing asthma relieving liquid
End enters in the body.Further, the tobacco tar input unit is additionally provided with air pump, and the air pump is removable installed in institute
Storage area is stated, and the output end of the air pump connects with the first injection branch, the second injection branch and the 3rd injection branch respectively
It is logical, for passing through the first injection branch, the second injection branch and the 3rd injection branch after the mixed zone mixing asthma relieving liquid respectively
It is pumped into gas and the atomizer is entered with tobacco tar of relievining asthma described in pushing in the storage area and the input end, so as to realizes
The tobacco tar input unit passes through the input end when controlled and inputs tobacco tar of being relievingd asthma described in predetermined quantity to the atomizer.
It should be noted that other embodiments of the invention also include, the mutually group of the technical characteristic in the various embodiments described above
Close relieving asthma tobacco tar and electronic cigarette of relievining asthma formed, can implementing.
Each technical characteristic of embodiment described above can be combined arbitrarily, to make description succinct, not to above-mentioned reality
Apply all possible combination of each technical characteristic in example to be all described, as long as however, the combination of these technical characteristics is not deposited
In contradiction, the scope that this specification is recorded all is considered to be.
Embodiment described above only expresses the several embodiments of the present invention, and its description is more specific and detailed, but simultaneously
Can not therefore it be construed as limiting the scope of the patent.It should be pointed out that come for one of ordinary skill in the art
Say, without departing from the inventive concept of the premise, various modifications and improvements can be made, these belong to the protection of the present invention
Scope.Therefore, the protection domain of patent of the present invention should be determined by the appended claims.
Claims (10)
- The tobacco tar 1. one kind is relievingd asthma, it is characterised in that by mass percentage including base oil 89%~95% and asthma relieving liquid 5%~ 11%；Wherein, the base oil includes glycerine and propane diols；The asthma relieving liquid is obtained using each proportioning component decocting liquid of following mass fraction：2.5~3.5 parts of Chinese ephedra, cassia twig 1.5~ 0.5~1.5 part of 2.5 parts, 1.5~2.5 parts of almond and radix glycyrrhizae.
- 2. tobacco tar of relievining asthma according to claim 1, it is characterised in that the mass ratio of glycerine and propane diols for (1.5~ 3.5):1。
- 3. tobacco tar of relievining asthma according to claim 2, it is characterised in that the mass ratio of glycerine and propane diols is 2:1.
- 4. tobacco tar of relievining asthma according to claim 1, it is characterised in that the asthma relieving liquid uses each proportioning of following mass fraction Component decocting liquid obtains：0.8~1.2 part of 2.8~3.2 parts of Chinese ephedra, 1.8~2.2 parts of cassia twig, 1.8~2.2 parts of almond and radix glycyrrhizae.
- 5. tobacco tar of relievining asthma according to claim 1, it is characterised in that the asthma relieving liquid uses each proportioning of following mass fraction Component decocting liquid obtains：1 part of 3 parts of Chinese ephedra, 2 parts of cassia twig, 2 parts of almond and radix glycyrrhizae.
- 6. tobacco tar of relievining asthma according to claim 1, it is characterised in that Chinese ephedra goes section to handle.
- 7. tobacco tar of relievining asthma according to claim 1, it is characterised in that cassia twig peeling is handled.
- 8. tobacco tar of relievining asthma according to claim 1, it is characterised in that almond peeling point processing.
- 9. tobacco tar of relievining asthma according to claim 1, it is characterised in that radix glycyrrhizae is to process radix glycyrrhizae processed.
- The electronic cigarette 10. one kind is relievingd asthma, it is characterised in that including the main frame, atomizer and cigarette holder being linked in sequence, in the atomizer Set just like tobacco tar of being relievingd asthma any one of claim 1 to 9.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711058797.0A CN107822195A (en) | 2017-11-01 | 2017-11-01 | Relieving asthma and tobacco tar and relieving asthma electronic cigarette |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711058797.0A CN107822195A (en) | 2017-11-01 | 2017-11-01 | Relieving asthma and tobacco tar and relieving asthma electronic cigarette |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107822195A true CN107822195A (en) | 2018-03-23 |
Family
ID=61651387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711058797.0A Withdrawn CN107822195A (en) | 2017-11-01 | 2017-11-01 | Relieving asthma and tobacco tar and relieving asthma electronic cigarette |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107822195A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11206872B2 (en) | 2020-04-07 | 2021-12-28 | Consumernext Labs Gmbh | Stable-foam dispensing device and cartridge |
-
2017
- 2017-11-01 CN CN201711058797.0A patent/CN107822195A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11206872B2 (en) | 2020-04-07 | 2021-12-28 | Consumernext Labs Gmbh | Stable-foam dispensing device and cartridge |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104770863B (en) | Electronic cigarette liquid with herbal tea flavor and application thereof | |
| CN104126865B (en) | The method of cigarette toxicity reduction liquid, its preparation method and reduction tobacco toxicity | |
| CN104983066B (en) | A kind of substitute of tobacco and preparation method thereof | |
| CN104585255A (en) | Mosquito-repelling bactericide | |
| WO2013097164A1 (en) | Alternative cut tobacco composition and preparation method thereof | |
| WO2021068464A1 (en) | Heat-not-burn vapor generating body and preparation method therefor, tobacco product and vapor generating body | |
| CN105146736A (en) | Health-care cigarette and preparation method thereof | |
| CN106723301A (en) | Tobacco juice for electronic smoke | |
| CN105341996A (en) | Electronic cigarette liquid and preparation method thereof | |
| CN104068468A (en) | Hookah fruit tobacco for electronic smoking set and traditional hookah smoking set and preparing method of hookah fruit tobacco | |
| CN105982346A (en) | Non-tobacco-plant-leaf cigarette | |
| CN107668767A (en) | Resolving sputum tobacco tar and resolving sputum electronic cigarette | |
| CN104381703A (en) | Dog food and preparation method thereof | |
| CN113662234B (en) | Antibacterial atomized liquid and preparation method thereof | |
| CN108851194A (en) | A kind of honeysuckle health care cigarette and preparation method thereof | |
| CN101606756A (en) | Green tea cigarette and production method thereof | |
| CN104256887A (en) | Acanthopanax health-care cigarette | |
| CN107822195A (en) | Relieving asthma and tobacco tar and relieving asthma electronic cigarette | |
| CN108949347A (en) | Increase the essence and its preparation method and application for heating the new cigarette flue gas moist feeling that do not burn | |
| CN105105315B (en) | A kind of clear throat type tobacco powder spray and preparation method thereof | |
| CN1241502C (en) | Incense rod for refreshment | |
| CN107549881A (en) | Cough-relieving tobacco tar and cough-relieving electronic cigarette | |
| CN106723307A (en) | Folium Taraxacum non-tobacco cigarette and preparation method thereof | |
| CN100486469C (en) | Medicated cigarette-type smoking quitting product and production method thereof | |
| CN107752132A (en) | Mulberry apricot tobacco tar and mulberry apricot electronic cigarette |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180323 |